PATHSTONE FAMILY OFFICE, LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 216 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
PATHSTONE FAMILY OFFICE, LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$57,724
+287.0%
148,392
+344.2%
0.00%
Q2 2023$14,914
-48.7%
33,403
-5.8%
0.00%
Q1 2023$29,073
-76.6%
35,455
-55.5%
0.00%
-100.0%
Q4 2022$124,350
-12.0%
79,712
-2.3%
0.00%0.0%
Q3 2022$141,372
+93.5%
81,590
+93.1%
0.00%
-50.0%
Q2 2022$73,079
+1.5%
42,242
+109.6%
0.00%0.0%
Q1 2022$72,000
-28.7%
20,156
-0.5%
0.00%
-33.3%
Q4 2021$101,000
-26.3%
20,255
+5.9%
0.00%
-25.0%
Q3 2021$137,000
-8.1%
19,133
+18.8%
0.00%0.0%
Q2 2021$149,00016,1010.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders